Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomas
Abstract The molecular profiling of gliomas for isocitrate dehydrogenase (IDH) mutations currently relies on resected tumor samples, highlighting the need for non-invasive, preoperative biomarkers. We investigated the integration of glioma polygenic risk scores (PRS) and radiographic features for pr...
Saved in:
| Main Authors: | Taishi Nakase, George A. Henderson, Thomas Barba, Rohan Bareja, Geno Guerra, Qingyu Zhao, Stephen S. Francis, Olivier Gevaert, Linda Kachuri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00980-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting p53 Status in IDH‐Mutant Gliomas Using MRI‐Based Radiomic Model
by: Jiamin Li, et al.
Published: (2025-08-01) -
MRI transformer deep learning and radiomics for predicting IDH wild type TERT promoter mutant gliomas
by: Wenju Niu, et al.
Published: (2025-03-01) -
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survival
by: Linda Kachuri, et al.
Published: (2025-01-01) -
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
by: Kristian A. Choate, et al.
Published: (2024-10-01) -
Radiomic study on preoperative multi‐modal magnetic resonance images identifies IDH‐mutant TERT promoter‐mutant gliomas
by: Haoyu Wang, et al.
Published: (2023-02-01)